Aminobenzoic acids and derivatives
Chemscene 2-(Phenylthio)acetic acid | 100g | CS-W016037 | 98% | 103-04-8 | MFCD00004355 | 168 22 | C8H8O2S
Chemscene | 2-(Phenylthio)acetic acid | 100g | CS-W016037 | 98% | 103-04-8 | MFCD00004355 | 168 22 | C8H8O2S
Chemscene 2-Amino-3-(1H-imidazol-4-yl)propanoic acid hydrochloride hydrate | 100g | CS-W015138 | 98% | 123333-71-1 | MFCD00151028 | 209 63 | C6H12ClN3O3
Chemscene | 2-Amino-3-(1H-imidazol-4-yl)propanoic acid hydrochloride hydrate | 100g | CS-W015138 | 98% | 123333-71-1 | MFCD00151028 | 209 63 | C6H12ClN3O3
Chemscene 4-Ethylphenol | 500g | CS-W013552 | 98% | 123-07-9 | MFCD00002393 | 122 17 | C8H10O
Chemscene | 4-Ethylphenol | 500g | CS-W013552 | 98% | 123-07-9 | MFCD00002393 | 122 17 | C8H10O
Chemscene 2-Fluoro-5-(trifluoromethyl)benzoic acid | 5g | CS-W015233 | 98% | 115029-23-7 | MFCD00061292 | 208 11 | C8H4F4O2
Chemscene | 2-Fluoro-5-(trifluoromethyl)benzoic acid | 5g | CS-W015233 | 98% | 115029-23-7 | MFCD00061292 | 208 11 | C8H4F4O2
Chemscene 1 3-Diphenylurea | 100g | CS-W015002 | 98% | 102-07-8 | MFCD00003017 | 212 25 | C13H12N2O
Chemscene | 1 3-Diphenylurea | 100g | CS-W015002 | 98% | 102-07-8 | MFCD00003017 | 212 25 | C13H12N2O
Chemscene 4-(Piperidin-1-yl)benzaldehyde | 5g | CS-W015933 | 98% | 10338-57-5 | MFCD00778395 | 189 26 | C12H15NO
Chemscene | 4-(Piperidin-1-yl)benzaldehyde | 5g | CS-W015933 | 98% | 10338-57-5 | MFCD00778395 | 189 26 | C12H15NO
Chemscene 4-Methoxy-2-(trifluoromethyl)benzaldehyde | 25g | CS-W015422 | 98% | 106312-36-1 | MFCD01091011 | 204 15 | C9H7F3O2
Chemscene | 4-Methoxy-2-(trifluoromethyl)benzaldehyde | 25g | CS-W015422 | 98% | 106312-36-1 | MFCD01091011 | 204 15 | C9H7F3O2
Chemscene 1 3-Bis(tert-butoxycarbonyl)-2-methyl-2-thiopseudourea | 100g | CS-W008142 | 98% | 107819-90-9 | MFCD00239356 | 290 38 | C12H22N2O4S
Chemscene | 1 3-Bis(tert-butoxycarbonyl)-2-methyl-2-thiopseudourea | 100g | CS-W008142 | 98% | 107819-90-9 | MFCD00239356 | 290 38 | C12H22N2O4S
Chemscene Hexane-1 2 6-triol | 500g | CS-W013379 | 98% | 106-69-4 | MFCD00002976 | 134 18 | C6H14O3
Chemscene | Hexane-1 2 6-triol | 500g | CS-W013379 | 98% | 106-69-4 | MFCD00002976 | 134 18 | C6H14O3
Chemscene (((9H-Fluoren-9-yl)methoxy)carbonyl)-D-serine | 1g | CS-W014509 | 98% | 116861-26-8 | MFCD00077068 | 327 34 | C18H17NO5
Chemscene | (((9H-Fluoren-9-yl)methoxy)carbonyl)-D-serine | 1g | CS-W014509 | 98% | 116861-26-8 | MFCD00077068 | 327 34 | C18H17NO5
Chemscene 4-Diethylaminobenzaldehyde | 100g | CS-W017361 | 98% | 120-21-8 | MFCD00003382 | 177 25 | C11H15NO
Chemscene | 4-Diethylaminobenzaldehyde | 100g | CS-W017361 | 98% | 120-21-8 | MFCD00003382 | 177 25 | C11H15NO
Medchemexpress LLC 3-(2-(2-aminoethoxy)ethoxy)propanoic acid | 791028-27-8 | MFCD20926377 | 99.7% | 177.20 | C7H15NO4 | 500 MG
Amino-PEG2-C2-acid is a cleavable three-unit polyethylene glycol (PEG) linker intended for research use in the synthesis of antibody-drug conjugates (ADCs) and PROTACs. It provides an amino-functionalized PEG spacer with a terminal propanoic acid group that facilitates conjugation chemistry and linker optimization in bioconjugation workflows.
- Cleavable three-unit PEG spacer suitable for ADC and PROTAC synthesis.
- Amino-functionalized for straightforward conjugation chemistry.
- Terminal carboxylic acid enables diverse coupling strategies.
- Reported high purity supports research applications.
- Available in multiple package sizes, including a 500 mg option.
![eMolecules (7-METHOXY-5-METHYLBENZO[B]THIOPHEN-2-YL)BORONIC ACID | 1443531-60-9 | MFCD26406768 | 1g](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502181026.JPG-250.jpg)
eMolecules (7-METHOXY-5-METHYLBENZO[B]THIOPHEN-2-YL)BORONIC ACID | 1443531-60-9 | MFCD26406768 | 1g
AstaTech | (7-METHOXY-5-METHYLBENZO[B]THIOPHEN-2-YL)BORONIC ACID | 1g | 222804981 | 83597 | 95.000 | 1443531-60-9 | MFCD26406768 | 222.070 | C10H11BO3S
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Chemscene Lipoic acid | 5g | CS-5076 | 98% | 1200-22-2 | MFCD01631142 | 206 33 | C8H14O2S2
Chemscene | Lipoic acid | 5g | CS-5076 | 98% | 1200-22-2 | MFCD01631142 | 206 33 | C8H14O2S2
Medchemexpress LLC Enasidenib mesylate | 1650550-25-6 | MFCD30489472 | 99.9% | 569.48 g/mol | C20H21F6N7O4S | 10 MG
Enasidenib mesylate is a reversible, selective inhibitor of mutant isocitrate dehydrogenase 2 (IDH2) used in research to study IDH2-mutant leukemia biology and differentiation. It reverses mutant IDH2-mediated epigenetic changes and impairs self-renewal of mutant leukemia cells. Supplied as a high-purity solid for in vitro applications.
- Potent, reversible inhibitor of mutant IDH2.
- Reverses mutant IDH2 effects on DNA methylation.
- High purity suitable for biochemical and cellular assays.
- Solid form for stable storage and handling.
- Recommended solvent: DMSO for sample preparation.
- Store sealed, away from moisture to maintain stability.